Washington, DC, United States of America

Howard Boudreau


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Howard Boudreau in Cancer Research

Introduction

Howard Boudreau is an accomplished inventor based in Washington, DC. He has made significant contributions to the field of cancer research through his innovative work on gene modulation. His research focuses on the diagnostic and therapeutic applications of specific genes in cancer treatment.

Latest Patents

Boudreau holds a patent for the gene BRCC-3 and its diagnostic and therapeutic uses. This gene acts as a modulator of tumor growth and metastasis in certain cancer types. The patent highlights the potential of BRCC-3 in detecting and treating cancers, particularly breast cancer and lung cancer.

Career Highlights

Boudreau is affiliated with Georgetown University, where he conducts his research. His work has garnered attention for its implications in cancer diagnostics and treatment strategies. He has dedicated his career to advancing the understanding of cancer biology and improving patient outcomes.

Collaborations

Boudreau has collaborated with notable colleagues, including Usha Kasid and Prafulla Gokhale. These partnerships have enriched his research and contributed to the development of innovative cancer therapies.

Conclusion

Howard Boudreau's contributions to cancer research through his patent on the BRCC-3 gene exemplify the impact of innovation in medical science. His work continues to pave the way for advancements in cancer diagnostics and treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…